Basic Information
| RNALocate ID: | RLID-D:11000793 |
| RNA Symbol: | hsa-miR-1277-3p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-1277-3p |
| RNA ID: | miRBase:MIMAT0005933 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Mesenchymal stem cells |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11004349 | Exosome | Plasma | 23663360 |
| RLID-D:11001725 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-1277-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-08913 |
| MNDR | hsa-miR-1277-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-08914 |
| MNDR | hsa-miR-1277-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-08915 |
| MNDR | hsa-miR-1277-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-08916 |
| MNDR | hsa-miR-1277-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-08917 |
| MNDR | hsa-miR-1277-3p | Her2-receptor positive breast cancer | MNDR-E-MI-08918 |
| MNDR | hsa-miR-1277-3p | Prostate cancer | MNDR-E-MI-08919 |
| MNDR | hsa-miR-1277-3p | Gastric cancer | MNDR-E-MI-08920 |
| MNDR | hsa-miR-1277-3p | Lung cancer | MNDR-E-MI-08921 |
| MNDR | hsa-miR-1277-3p | Parkinson disease | MNDR-E-MI-08922 |
| MNDR | hsa-miR-1277-3p | Breast cancer | MNDR-E-MI-08923 |
| MNDR | hsa-miR-1277-3p | Pancreatic cancer | MNDR-E-MI-08924 |
| MNDR | hsa-miR-1277-3p | Melanoma | MNDR-E-MI-08925 |
| MNDR | hsa-miR-1277-3p | Colon cancer | MNDR-E-MI-08926 |
| MNDR | hsa-miR-1277-3p | Familial ovarian cancer | MNDR-E-MI-08927 |
| MNDR | hsa-miR-1277-3p | Prostate adenocarcinoma | MNDR-E-MI-08928 |
| MNDR | hsa-miR-1277-3p | Carcinoma ductal breast | MNDR-E-MI-08929 |
| MNDR | hsa-miR-1277-3p | Breast carcinoma | MNDR-E-MI-08930 |
| MNDR | hsa-miR-1277-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-08931 |
| MNDR | hsa-miR-1277-3p | Lung squamous cell carcinoma | MNDR-E-MI-08932 |
| MNDR | hsa-miR-1277-3p | Lung adenocarcinoma | MNDR-E-MI-08933 |
| MNDR | hsa-miR-1277-3p | Thyroid carcinoma | MNDR-E-MI-08934 |
| MNDR | hsa-miR-1277-3p | Bladder urothelial carcinoma | MNDR-E-MI-08935 |
| MNDR | hsa-miR-1277-3p | Kidney renal clear cell carcinoma | MNDR-E-MI-08936 |
| MNDR | hsa-miR-1277-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-08937 |
| MNDR | hsa-miR-1277-3p | Renal clear cell carcinoma | MNDR-E-MI-08938 |
| MNDR | hsa-miR-1277-3p | Cholangiocarcinoma | MNDR-E-MI-08939 |
| MNDR | hsa-miR-1277-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-08940 |
| MNDR | hsa-miR-1277-3p | Testicular germ cell cancer | MNDR-E-MI-08941 |
| MNDR | hsa-miR-1277-3p | Breast invasive carcinoma | MNDR-E-MI-08942 |
| MNDR | hsa-miR-1277-3p | Familiar ovarian carcinoma | MNDR-E-MI-08943 |
| MNDR | hsa-miR-1277-3p | Colorectal cancer | MNDR-E-MI-08944 |
| MNDR | hsa-miR-1277-3p | Nasopharynx carcinoma | MNDR-E-MI-08945 |
| MNDR | hsa-miR-1277-3p | Nasopharyngeal cancer | MNDR-E-MI-08946 |
| MNDR | hsa-miR-1277-3p | Breast cancer her3+ negative | MNDR-E-MI-08947 |
TOP